A. G. G. Turpie

3.6k total citations
41 papers, 956 citations indexed

About

A. G. G. Turpie is a scholar working on Cardiology and Cardiovascular Medicine, Internal Medicine and Genetics. According to data from OpenAlex, A. G. G. Turpie has authored 41 papers receiving a total of 956 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Cardiology and Cardiovascular Medicine, 22 papers in Internal Medicine and 7 papers in Genetics. Recurrent topics in A. G. G. Turpie's work include Venous Thromboembolism Diagnosis and Management (22 papers), Atrial Fibrillation Management and Outcomes (11 papers) and Acute Myocardial Infarction Research (7 papers). A. G. G. Turpie is often cited by papers focused on Venous Thromboembolism Diagnosis and Management (22 papers), Atrial Fibrillation Management and Outcomes (11 papers) and Acute Myocardial Infarction Research (7 papers). A. G. G. Turpie collaborates with scholars based in Canada, United Kingdom and Italy. A. G. G. Turpie's co-authors include G. P. McNicol, A. S. Douglas, J. Douketis, David R. Anderson, Clive Kearon, Susan Solymoss, Louis Desjardins, Marc Rodger, Susan R. Kahn and M.J. Kovacs and has published in prestigious journals such as Nature, The Lancet and Circulation.

In The Last Decade

A. G. G. Turpie

39 papers receiving 874 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. G. G. Turpie Canada 15 575 516 213 134 104 41 956
Alexander G.G. Turpie Canada 18 952 1.7× 663 1.3× 261 1.2× 113 0.8× 109 1.0× 28 1.2k
G. Freyburger France 16 174 0.3× 243 0.5× 211 1.0× 187 1.4× 148 1.4× 34 881
Michele Arcopinto Italy 17 478 0.8× 131 0.3× 124 0.6× 33 0.2× 116 1.1× 41 997
Mark T. Cunningham United States 15 233 0.4× 275 0.5× 219 1.0× 275 2.1× 98 0.9× 43 732
Erik Myhre Norway 16 471 0.8× 126 0.2× 209 1.0× 95 0.7× 86 0.8× 47 950
Pasquale Parise Italy 17 209 0.4× 323 0.6× 148 0.7× 163 1.2× 146 1.4× 35 712
Bregtje A. Lemkes Netherlands 8 209 0.4× 80 0.2× 131 0.6× 55 0.4× 144 1.4× 13 942
Richard C. Becker United States 15 449 0.8× 160 0.3× 196 0.9× 88 0.7× 46 0.4× 35 681
Akio Hirayama Japan 8 147 0.3× 157 0.3× 112 0.5× 266 2.0× 86 0.8× 23 690
Thomas Aherne Ireland 16 273 0.5× 366 0.7× 772 3.6× 9 0.1× 197 1.9× 63 1.1k

Countries citing papers authored by A. G. G. Turpie

Since Specialization
Citations

This map shows the geographic impact of A. G. G. Turpie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. G. G. Turpie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. G. G. Turpie more than expected).

Fields of papers citing papers by A. G. G. Turpie

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. G. G. Turpie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. G. G. Turpie. The network helps show where A. G. G. Turpie may publish in the future.

Co-authorship network of co-authors of A. G. G. Turpie

This figure shows the co-authorship network connecting the top 25 collaborators of A. G. G. Turpie. A scholar is included among the top collaborators of A. G. G. Turpie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. G. G. Turpie. A. G. G. Turpie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Turpie, A. G. G., et al.. (2011). The ultra-low molecular weight heparin (ULMWH) semuloparin for prevention of venous thromboembolism (VTE) in patients with cancer receiving chemotherapy: SAVE ONCO study.. Journal of Clinical Oncology. 29(15_suppl). LBA9014–LBA9014. 9 indexed citations
2.
Fiessinger, J N, Henri Bounameaux, Marc Cairols, et al.. (2010). Thromboxane Antagonism with terutroban in Peripheral Arterial Disease: the TAIPAD study. Journal of Thrombosis and Haemostasis. 8(11). 2369–2376. 24 indexed citations
3.
Poller, L., Chris Roberts, Said A. Ibrahim, et al.. (2009). Screening computer‐assisted dosage programs for anticoagulation with warfarin and other vitamin K antagonists: minimum safety requirements for individual programs. Journal of Thrombosis and Haemostasis. 7(10). 1736–1736. 7 indexed citations
4.
Dahl, O.E., Bengt I. Eriksson, Martin Homering, et al.. (2009). THE EFFECT OF PATIENT AGE, GENDER AND WEIGHT ON THE EFFICACY AND SAFETY OF RIVAROXABAN (BAY 59-7939) FOR THE PREVENTION OF VENOUS THROMBOEMBOLISM AFTER MAJOR ORTHOPAEDIC SURGERY. 76–76. 1 indexed citations
5.
Poller, L., Michelle Keown, Said A. Ibrahim, et al.. (2008). An international multicenter randomized study of computer-assisted oral anticoagulant dosage vs. medical staff dosage. Journal of Thrombosis and Haemostasis. 6(6). 935–943. 90 indexed citations
6.
Davidson, Bruce L., A. G. G. Turpie, Clifford W. Colwell, & Louis M. Kwong. (2004). Early vs delayed initiation of fondaparinux prophylaxis to prevent postoperative pulmonary embolism: A clinical endpoint study. CHEST Journal. 126(4). 783S–783S. 1 indexed citations
7.
Gent, Michael, J.A. Julian, Kenneth A. Bauer, et al.. (2004). Bilateral vs. ipsilateral venography as the primary efficacy outcome measure in thromboprophylaxis clinical trials: a systematic review. Journal of Thrombosis and Haemostasis. 2(10). 1752–1759. 18 indexed citations
8.
Ageno, Walter & A. G. G. Turpie. (2002). Low molecular weight heparins in the treatment of unstable angina.. PubMed. 50(6). 643–51. 1 indexed citations
9.
Verheugt, Freek W.A., Richard C. Becker, M Bertrand, et al.. (1999). Management strategies in unstable coronary artery disease—Current problems and future directions. Clinical Cardiology. 22(9). 551–553. 1 indexed citations
10.
Turpie, A. G. G. & A Kher. (1998). Prevention of Venous Thrombosis After Elective Hip Surgery. Orthopedics. 21(12). 1275–1281. 2 indexed citations
11.
Turpie, A. G. G.. (1990). Enoxaparin prophylaxis in elective hip surgery.. PubMed. 556. 103–7. 8 indexed citations
12.
Turpie, A. G. G., R Butt, & Edward Genton. (1981). Contribution of increased fibrinolysis induced by intermittent pneumatic compression of the legs in the prevention of deep vein thrombosis. Thrombosis and Haemostasis. 46(1). 191. 1 indexed citations
13.
Turpie, A. G. G. & J. Hirsh. (1978). PLATELET SUPPRESSIVE THERAPY. British Medical Bulletin. 34(2). 183–190. 14 indexed citations
14.
Larke, R. P. B., A. G. G. Turpie, Sofia Scott, & M. A. Chernesky. (1977). Paramyxovirus-induced platelet aggregation. Requirement for neuraminic acid receptors on platelets.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 37(2). 150–7. 5 indexed citations
15.
Turpie, A. G. G., G. P. McNicol, & A. S. Douglas. (1972). Platelet electrophoresis: effect of defibrination by ancrod (Arvin). Cardiovascular Research. 6(1). 101–108. 4 indexed citations
16.
Turpie, A. G. G., C. R. M. Prentice, G. P. McNicol, & A. S. Douglas. (1971). In‐Vitro Studies with Ancrod (‘Arvin’). British Journal of Haematology. 20(2). 217–224. 14 indexed citations
17.
Turpie, A. G. G., et al.. (1970). Effect of RA233 on Platelet Function In Vitro. BMJ. 2(5701). 83–86. 18 indexed citations
18.
Macdougall, A.I., et al.. (1970). Treatment of Hypertension with Clonidine. BMJ. 3(5720). 440–442. 27 indexed citations
19.
Forbes, C.D., A. G. G. Turpie, Jenny Ferguson, G. P. McNicol, & A. S. Douglas. (1969). Effect of gaboon viper ( Bitis gabonica ) venom on blood coagulation, platelets, and the fibrinolytic enzyme system. Journal of Clinical Pathology. 22(3). 312–316. 17 indexed citations
20.
Turpie, A. G. G., C.D. Forbes, & G. P. McNicol. (1967). Idiopathic gangrene in African children.. BMJ. 3(5566). 646–648. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026